BYSI
BeyondSpring Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.51
−8.28%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.54
- Revenue estimate
- $8.8M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.02
- EPS estimate
- -$0.54
- Revenue actual
- —
- Revenue estimate
- $8.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +86.2%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.54 | -$0.02 | Beat 96.30% | — |
| May 13, 2026 | -$0.54 | -$0.05 | Beat 90.74% | — |
| Mar 25, 2026 | -$0.54 | -$0.05 | Beat 90.26% | — |
| Nov 12, 2025 | — | -$0.05 | — | — |
| Aug 13, 2025 | — | -$0.04 | — | — |
| Mar 27, 2025 | — | $0.08 | — | -$1.4M |
| Aug 9, 2024 | — | -$0.09 | — | $500.0K |
| Apr 11, 2024 | — | -$0.09 | — | — |
| Feb 28, 2024 | — | -$0.16 | — | — |
| Apr 18, 2023 | -$0.58 | -$0.19 | Beat 67.41% | — |
| Feb 28, 2023 | — | -$0.24 | — | $338.0K |
| Apr 14, 2022 | -$0.26 | -$0.24 | Beat 7.69% | $338.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026